Maohong Zhang

408 total citations
20 papers, 305 citations indexed

About

Maohong Zhang is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Maohong Zhang has authored 20 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Maohong Zhang's work include Bioactive Natural Diterpenoids Research (4 papers), Platelet Disorders and Treatments (3 papers) and Cell death mechanisms and regulation (3 papers). Maohong Zhang is often cited by papers focused on Bioactive Natural Diterpenoids Research (4 papers), Platelet Disorders and Treatments (3 papers) and Cell death mechanisms and regulation (3 papers). Maohong Zhang collaborates with scholars based in China and United States. Maohong Zhang's co-authors include Jun Peng, Ming Hou, Xuebin Ji, Xueyong Wang, Ping Qin, Chunqing Zhang, Yan Shi, Qu Lin, Ming Hou and Xiangyuan Wu and has published in prestigious journals such as Thrombosis Research, American Journal of Hematology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Maohong Zhang

20 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maohong Zhang China 9 152 104 55 51 29 20 305
Ling Pan China 12 106 0.7× 159 1.5× 30 0.5× 23 0.5× 29 1.0× 32 305
José Padilla Spain 15 238 1.6× 101 1.0× 30 0.5× 26 0.5× 60 2.1× 40 411
Guowei Dai China 9 156 1.0× 268 2.6× 39 0.7× 28 0.5× 55 1.9× 18 451
Yunfeng Shen China 12 101 0.7× 111 1.1× 66 1.2× 64 1.3× 96 3.3× 29 309
James P. O’Callaghan Australia 8 99 0.7× 33 0.3× 72 1.3× 83 1.6× 41 1.4× 9 340
Baodong Ye China 11 132 0.9× 135 1.3× 31 0.6× 13 0.3× 61 2.1× 62 318
Diane M. Pierson United States 9 32 0.2× 111 1.1× 44 0.8× 33 0.6× 40 1.4× 11 324
Yehua Jin China 10 46 0.3× 135 1.3× 48 0.9× 31 0.6× 27 0.9× 15 309
Liye Zhong China 10 49 0.3× 91 0.9× 79 1.4× 55 1.1× 41 1.4× 29 239
Linshuai Xu China 11 43 0.3× 164 1.6× 63 1.1× 25 0.5× 18 0.6× 16 339

Countries citing papers authored by Maohong Zhang

Since Specialization
Citations

This map shows the geographic impact of Maohong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maohong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maohong Zhang more than expected).

Fields of papers citing papers by Maohong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maohong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maohong Zhang. The network helps show where Maohong Zhang may publish in the future.

Co-authorship network of co-authors of Maohong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Maohong Zhang. A scholar is included among the top collaborators of Maohong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maohong Zhang. Maohong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Maohong, et al.. (2019). Research on Topic Mining Algorithm Based on Deep Learning Extension. Journal of Physics Conference Series. 1345(4). 42034–42034. 3 indexed citations
2.
Zhang, Maohong, et al.. (2016). Research of mobile learning mode based on WeChat public platform. 18. 489–492. 1 indexed citations
3.
Qin, Xuemei, et al.. (2015). Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review. OncoTargets and Therapy. 8. 3707–3707. 8 indexed citations
4.
Li, Yanxiang, et al.. (2013). Efficacy of glycyrrhizin combined with cyclosporine in the treatment of non-severe aplastic anemia. Chinese Medical Journal. 126(11). 2083–2086. 6 indexed citations
5.
Chen, Feng, Chunqing Zhang, Wen Wang, et al.. (2007). A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis. Leukemia Research. 32(4). 665–667. 2 indexed citations
6.
Wang, Xiuwen, et al.. (2007). [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].. PubMed. 26(8). 870–3. 2 indexed citations
7.
Wang, Wen, et al.. (2007). [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].. PubMed. 28(10). 681–4. 3 indexed citations
9.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2006). Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. American Journal of Hematology. 81(2). 86–94. 20 indexed citations
10.
Zhang, Pin, Feng-yi Feng, Lingying Wu, et al.. (2006). [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].. PubMed. 28(3). 230–4. 9 indexed citations
11.
Qin, Ping, Ming Hou, Jianzhi Sun, et al.. (2005). [Study on the direct MAIPA technique in the differential diagnosis of immune and non-immune thrombocytopenia].. PubMed. 26(3). 167–9. 1 indexed citations
12.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2005). Apoptotic effect of oridonin on NB4 cells and its mechanism. Leukemia & lymphoma. 46(4). 593–597. 13 indexed citations
13.
Liu, Jiajun, Huiling Lü, Renwei Huang, et al.. (2005). Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemotherapy and Pharmacology. 56(4). 400–408. 44 indexed citations
14.
Liu, Jiajun, Renwei Huang, Dongjun Lin, et al.. (2005). Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro. Oncology Reports. 13(4). 653–7. 15 indexed citations
15.
Wang, Xingyuan, Feng-yi Feng, Santai Song, et al.. (2005). [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].. PubMed. 27(6). 373–6. 3 indexed citations
16.
Li, Xiangxin, et al.. (2005). [A randomized controlled and multicenter clinical study of ferrous L-threonate in treatment of iron deficiency anemia].. PubMed. 44(11). 844–7. 2 indexed citations
17.
Peng, Jun, Chuanfang Liu, Yuanyuan Zhu, et al.. (2003). The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR. Human Immunology. 64(9). 896–901. 23 indexed citations
18.
Hou, Ming, Jun Peng, Yan Shi, et al.. (2003). Mycophenolate mofetil (MMF) for the treatment of steroid‐resistant idiopathic thrombocytopenic purpura. European Journal Of Haematology. 70(6). 353–357. 113 indexed citations
19.
Hou, Ming, Lu Lu, Yan Shi, et al.. (2003). Both splenic CD5+ B and CD5− B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP. Thrombosis Research. 110(1). 1–5. 10 indexed citations
20.
Zhou, Lin, et al.. (1990). Antithrombin III activity in chinese women with preeclampsia. Thrombosis Research. 59(2). 401–406. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026